Symptomatic and Promising Disease-Modifying Treatments for Dementia Syndromes

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

MOHAMMADIAN FATEMEH; MOHEBBI NIAYESH

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: JOURNAL OF PHARMACEUTICAL CARE Year:2022 | Volume:10 | Issue:3 Page(s): 94-96

Download Full-Text

View:

Download:

Cites:

Information Journal Paper

Title

Symptomatic and Promising Disease-Modifying Treatments for Dementia Syndromes

Author(s)

MOHAMMADIAN FATEMEH | MOHEBBI NIAYESH | Issue Writer Certificate

Keywords

Not Registered.

Abstract

Dementia could be defined as a range of cognitive and behavioral symptoms, including memory loss, executive dysfunction, and change in personality, and a reduction in a person’, s ability to carry out daily activities. The most common types of dementia are Alzheimer’, s disease (AD), vascular dementia, mixed dementia, dementia with Lewy bodies, and frontotemporal dementia (1). All currently approved treatments for dementia are symptomatic treatments that could influence cognitive and behavioral symptoms without changing the underlying neuropathological progression of the disease (2). The U. S. Food and Drug Administration (FDA) has approved six drugs for the treatment of Alzheimer’, s disease. Five of these drugs, including,Donepezil, Rivastigmine, Galantamine, Memantine, and Memantine, combined with donepezil temporarily treat Alzheimer’, s symptoms by increasing the number of neurotransmitters in the brain nevertheless, could not change the underlying brain changes of Alzheimer’, s and the course of the disease. (3, 4). ChE-Is could influence the loss of presynaptic cholinergic cells in the nucleus basalis of Meynert (5)...

Cites

No record.

References

Cite

APA: Copy

MOHAMMADIAN, FATEMEH, & MOHEBBI, NIAYESH. (2022). Symptomatic and Promising Disease-Modifying Treatments for Dementia Syndromes. JOURNAL OF PHARMACEUTICAL CARE, 10(3), 94-96. SID. https://sid.ir/paper/1007259/en

Vancouver: Copy

MOHAMMADIAN FATEMEH, MOHEBBI NIAYESH. Symptomatic and Promising Disease-Modifying Treatments for Dementia Syndromes. JOURNAL OF PHARMACEUTICAL CARE[Internet]. 2022;10(3):94-96. Available from: https://sid.ir/paper/1007259/en

IEEE: Copy

FATEMEH MOHAMMADIAN, and NIAYESH MOHEBBI, “Symptomatic and Promising Disease-Modifying Treatments for Dementia Syndromes,” JOURNAL OF PHARMACEUTICAL CARE, vol. 10, no. 3, pp. 94–96, 2022, [Online]. Available: https://sid.ir/paper/1007259/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops